Hematological Cancer Diagnosis and Treatment: An Interdisciplinary Approach

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital.  Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,500 scientific papers in the international journals.

Introduction to Stem Cell Therapy and Blood Cancers.- Cellular and Vaccine Based Immunotherapy for Hematologic Malignancies.- Molecular Signatures in Acute Myeloid Leukemia: From Diagnosis to Targeted Therapy and Drug Repositioning.- Shaping Progress: Exploring the Impact of Human Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on Acute Myeloid Leukemia.- DNA Methylation Alterations in Acute Myeloid Leukemia: Therapeutic Potential.- Unlocking the Power of Immune Microenvironment in AML Therapy: Current Insight and Future Prospects.- Modern Approach to Prognostication and Therapy of Chronic Lymphocytic Leukemia.- A Multidisciplinary Approach to Managing BTK Inhibitor Toxicity in Lymphoma and Chronic Lymphocytic Leukemia.- Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety.- Genomics and Epigenomics of Natural Killer/T cell Lymphoma: Diagnostic, Prognostic, and Therapeutic Implications.- BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma.- Measurable Residual Disease Detection in Hematolymphoid Malignancies: Techniques and Clinical Significance.